Medical conditions are specified in List. Specified medical conditions associated with increased risk of invasive meningococcal disease.

Age at start of vaccine course

MenB vaccine brand

Dose requirements for healthy people (without any medical conditions associated with increased risk of invasive meningococcal disease)

6 weeks to 5 months

Bexsero

3 doses (8 weeks between 1st and 2nd doses; 3rd dose at 12 months of age)

6–11 months

Bexsero

3 doses (8 weeks between 1st and 2nd doses; 3rd dose at 12 months of age or 8 weeks after 2nd dose, whichever is later)

12–23 months

Bexsero

2 doses (8 weeks between doses)

Previous

Table. Recommendations for immunisation of infants and children aged

Next

Table. Recommendations for MenACWY vaccine for people with a specified medical condition that increases their risk of invasive meningococcal disease

Last updated: 
5 June 2018
Last reviewed: 
5 June 2018